Pacerone Oral

This drug, when used in combination with certain cholesterol-lowering "statins" (atorvastatin, lovastatin, simvastatin), may infrequently cause muscle damage (which can rarely lead to a very serious condition called rhabdomyolysis). Tell your doctor immediately if you develop:

• muscle pain/tenderness/weakness (especially with fever or unusual tiredness)

Seek immediate medical attention if any of these unlikely but serious side effects occur:

• severe dizziness
• fainting
• sudden change in heartbeat (unusually faster/slower/more irregular)

Tell your doctor immediately if any of these unlikely but serious side effects occur:

• coldness
• sweating
• unexplained weight change
• lump/growth in the front of the neck (goiter)
• nervousness
• uncontrolled shaking/tremor
• sluggishness
• loss of coordination
• mental/mood changes
• tingling or numbness of the hands or feet
• swelling of the hands or feet
• return/worsening of irregular heartbeat
• vision changes (e.g., seeing halos, blurred vision, loss of vision)
• easy bruising/bleeding
• persistent sore throat
• change in the amount of urine

This drug may cause skin reactions similar to a serious sunburn. Infrequently with long-term amiodarone treatment, you may develop blue-gray discoloring of the skin, particularly of the face and hands. This effect is not harmful and usually reverses, sometimes incompletely, after the drug is stopped. Avoiding prolonged sun exposure may help to prevent this effect. See also Precautions.

In the unlikely event you have a serious allergic reaction to this drug, seek immediate medical attention. Symptoms of a serious allergic reaction include:

• rash
• itching
• swelling
• severe dizziness
• trouble breathing

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.

Pacerone Oral Medical Alert

Your condition can cause complications in a medical emergency. For enrollment information call MedicAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada).

Previous Section

Dosage and Storage

Next Section

Drug Interactions